Ayça Vitrinel, Gülay Çiler Erdag, Öznur Kılıç, Tuba Giray, Vural Kartal, Şinasi Yaman, Yasemin Akın

VISCERAL LEISHMANIASIS TREATED WITH LIPOSOMAL AMPHOTERICIN B

Three children under 5 years of age with visceral leishmaniasis, responded dramatically to a short course of liposomal amphotericin B (L-AmB) and are presented and discussed in the view of literature.Key Words: Leishmaniasis, Liposomal amphotericin B

PDF

___

I. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med tlyg 1992; 46 : 296-306.
Croft SL, Davidson RM, Thornton EA. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J Antimicrob Chemother 1991 ; 28 : 111-118.
Meyrhoff A.U.S. Pood and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999 ;28 : 42-48.
Qradoni L, Bryceson A, Desjeux P. Treatment of Mediterranean visceral leishmaniasis. Bull World Health Organ 1995 ; 73 :191-197.
Thakur CP, Kumar M, Kumar P, Mishra BM, Pandey AK. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. Br Med J 1988 ; 296 : 1557-1561.
Berman JD, Hanson WL, Chapman WL, Alving CR, Lopez-Berestein Q. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother 1986 ; 30 : 847-851.
Davidson RM, Croft SL, Scott AO, Maini M, Moody AH, Bryceson AOM. Liposomal amphotericin B in drug resistant visceral leishmaniasis. Lancet 1991 ; 337 : 1061- 1062
Davidson RM, Di Marti no L, Oradoni R, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi centre trial. Quart J Med 1994 ; 87 : 75-81.
Castagnola E, Davidson RM, Fiore P, et al. Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis. Trans Roy Soc Trop Med Hyg 1996 ; 90 : 31 7-318
Giacchino R, Giambartolome G, Tasso L, et al. Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis. Trans Roy Soc of Trop Med Hyg 1993 ; 87 : 310
Catania S, Arassa C, Tzahtzoglou S, et al. Visceral leishmaniasis treated with liposomal amphotericin B. Pediatr In fee Dis J 1999 ; 18: 73-74
Davidson RM, Martino L, G radon i L, et al. Short course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis 1996 ; 22 : 938-943.
Smith OP, Harm IM, Cox H, Movelli V. Visceral leishmaniasis: rapid response to AmBisome treatment. Arc Dis Child 1995 ; 73 : 157-159.
Sunder S, Agrawal G, Rai M, Makharia MK, Murray HW. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: Randomised trial. Br Med J 2001 ; 323 :419- 422.